Genetic Agency on Display at GATC 2025
BOSTON – Dyno Therapeutics hosted an ambitious event in Boston this week, the Genome Agency Technology Conference (GATC)*, striving to bring together a broad coalition of researchers and executives in cell and gene therapy,...
Accelerating Clinical Decisions Through Faster Access to Imaging Data
Register Now Panelists:
Yvete Toivola, PhD VP, Product ManagementFlywheel View Bio
Panelist ...
Pig kidney transplant breakthrough uncovers immune rejection secrets
Researchers have uncovered and then overcome an obstacle that has led to the failure of pioneering efforts in xenotransplantation, in which an animal kidney is transplanted into a human. More than 800,000 Americans have...
Cellarity’s AI model predicts drug-induced liver injury
Cellarity, a clinical-stage biotechnology company developing Cell State-Correcting therapies through integrated multi-omics and AI modeling, today announced the publication of a seminal manuscript in Nature Communications, which describes a novel framework for the prediction...
Shift Bioscience publishes improved metric calibration framework for robust genetic perturbation modeling using AI...
Shift Bioscience (Shift), a biotechnology company uncovering the biology of cell rejuvenation to end the morbidity and mortality of aging, today announced the release of new research detailing an improved framework for evaluating benchmark...
AI chat box helps investigate complex biology in English language
Using sophisticated RNA sequencing technology, biomedical researchers can measure the activity of our genes across millions of single cells, creating detailed maps of tissues, organs, and diseases. Analyzing these datasets requires a rare combination...
Dyno GATC Announces AI Agents, Muscle Capsid, and Manufacturing Partner
Boston — “If we want to treat and cure all disease, that will require enabling genetic agency,” said Eric Kelsic, PhD, co-founder and CEO of Dyno Therapeutics, in an interview with GEN. “AI will have...
Scientists pinpoint a reason Alzheimer’s patients forget loved ones
One of the most devastating moments for family members of a patient with Alzheimer's is when their loved one forgets who they are. New University of Virginia School of Medicine research may explain why...
Lilly Expands AI Ties to Insilico, from Customer to Drug Discovery Partner
Eli Lilly has been doing business with Insilico Medicine for two years before they announced plans this week to partner in artificial intelligence (AI)-based drug development, through a collaboration they said could generate “over...
StockWatch: Recursion Slides on Data Update as New CEO Named
Investors in Recursion (NASDAQ: RXRX) seemed only mildly fazed by Wednesday’s series of company announcements. The artificial intelligence (AI)-based drug developer’s stock barely moved on Wednesday, then dropped on Thursday, after reporting mixed third-quarter...
